Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;79(11-12):1702–1708. doi: 10.1038/sj.bjc.6690271

Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD)

V H Fingar 1, P K Kik 1, P S Haydon 1, P B Cerrito 2, M Tseng 3, E Abang 3, T J Wieman 1
PMCID: PMC2362794  PMID: 10206280

Abstract

Benzoporphyrin derivative monoacid ring A (BPD-MA, verteporfin) is currently under investigation as a photosensitizer for photodynamic therapy (PDT). Since BPD exhibits rapid pharmacokinetics in plasma and tissues, we assessed damage to tumour and muscle microvasculature when light treatment for PDT was given at short times after injection of photosensitizer. Groups of rats with chondrosarcoma were given 2 mg kg−1 of BPD intravenously 5 min to 180 min before light treatment of 150 J cm−2 690 nm. Vascular response was monitored using intravital microscopy and tumour cure was monitored by following regrowth over 42 days. For treatment at 5 or 30 min after BPD injection, blood flow stasis was limited to tumour microvasculature with lesser response in the surrounding normal microvasculature, indicating selective targeting for damage. No acute changes were observed in vessels when light was given 180 min after BPD injection. Tumour regression after light treatment occurred in all animals given PDT with BPD. Long-term tumour regression was greater in animals treated 5 min after BPD injection and least in animals given treatment 180 min after drug injection. The correlation between the timing for vascular damage and cure implies that blood flow stasis plays a significant role in PDT-induced tumour destruction. © 1999 Cancer Research Campaign

Keywords: photodynamic therapy; BPD; vascular effects, chondrosarcoma

Full Text

The Full Text of this article is available as a PDF (250.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison B. A., Crespo M. T., Jain A. K., Richter A. M., Hsiang Y. N., Levy J. G. Delivery of benzoporphyrin derivative, a photosensitizer, into atherosclerotic plaque of Watanabe heritable hyperlipidemic rabbits and balloon-injured New Zealand rabbits. Photochem Photobiol. 1997 May;65(5):877–883. doi: 10.1111/j.1751-1097.1997.tb01938.x. [DOI] [PubMed] [Google Scholar]
  2. Allison B. A., Pritchard P. H., Levy J. G. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. Br J Cancer. 1994 May;69(5):833–839. doi: 10.1038/bjc.1994.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allison B. A., Waterfield E., Richter A. M., Levy J. G. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol. 1991 Nov;54(5):709–715. doi: 10.1111/j.1751-1097.1991.tb02079.x. [DOI] [PubMed] [Google Scholar]
  4. Chowdhary R. K., Ratkay L. G., Neyndorff H. C., Richter A., Obochi M., Waterfield J. D., Levy J. G. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. Clin Immunol Immunopathol. 1994 Aug;72(2):255–263. doi: 10.1006/clin.1994.1139. [DOI] [PubMed] [Google Scholar]
  5. Fielding P. E., Vlodavsky I., Gospodarowicz D., Fielding C. J. Effect of contact inhibition on the regulation of cholesterol metabolism in cultured vascular endothelial cells. J Biol Chem. 1979 Feb 10;254(3):749–755. [PubMed] [Google Scholar]
  6. Fingar V. H., Henderson B. W. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem Photobiol. 1987 Nov;46(5):837–841. doi: 10.1111/j.1751-1097.1987.tb04856.x. [DOI] [PubMed] [Google Scholar]
  7. Fingar V. H., Wieman T. J., Doak K. W. Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. Cancer Res. 1990 May 1;50(9):2599–2603. [PubMed] [Google Scholar]
  8. Fingar V. H., Wieman T. J., Wiehle S. A., Cerrito P. B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 1992 Sep 15;52(18):4914–4921. [PubMed] [Google Scholar]
  9. Haimovici R., Kramer M., Miller J. W., Hasan T., Flotte T. J., Schomacker K. T., Gragoudas E. S. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res. 1997 Feb;16(2):83–90. doi: 10.1076/ceyr.16.2.83.5088. [DOI] [PubMed] [Google Scholar]
  10. Henderson B. W., Dougherty T. J. How does photodynamic therapy work? Photochem Photobiol. 1992 Jan;55(1):145–157. doi: 10.1111/j.1751-1097.1992.tb04222.x. [DOI] [PubMed] [Google Scholar]
  11. Korbelik M., Krosl G. Accumulation of benzoporphyrin derivative in malignant and host cell populations of the murine RIF tumor. Cancer Lett. 1995 Nov 6;97(2):249–254. doi: 10.1016/0304-3835(95)03985-6. [DOI] [PubMed] [Google Scholar]
  12. Levy J. G. Photosensitizers in photodynamic therapy. Semin Oncol. 1994 Dec;21(6 Suppl 15):4–10. [PubMed] [Google Scholar]
  13. Lin S. C., Lin C. P., Feld J. R., Duker J. S., Puliafito C. A. The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative. Curr Eye Res. 1994 Jul;13(7):513–522. doi: 10.3109/02713689408999883. [DOI] [PubMed] [Google Scholar]
  14. North J., Coombs R., Levy J. Photodynamic inactivation of free and cell-associated HIV-1 using the photosensitizer, benzoporphyrin derivative. J Acquir Immune Defic Syndr. 1994 Sep;7(9):891–898. [PubMed] [Google Scholar]
  15. Richter A. M., Cerruti-Sola S., Sternberg E. D., Dolphin D., Levy J. G. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. J Photochem Photobiol B. 1990 Apr 15;5(2):231–244. doi: 10.1016/1011-1344(90)80008-l. [DOI] [PubMed] [Google Scholar]
  16. Richter A. M., Waterfield E., Jain A. K., Allison B., Sternberg E. D., Dolphin D., Levy J. G. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. Br J Cancer. 1991 Jan;63(1):87–93. doi: 10.1038/bjc.1991.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Richter A. M., Waterfield E., Jain A. K., Canaan A. J., Allison B. A., Levy J. G. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem Photobiol. 1993 Jun;57(6):1000–1006. doi: 10.1111/j.1751-1097.1993.tb02962.x. [DOI] [PubMed] [Google Scholar]
  18. Schmidt-Erfurth U., Flotte T. J., Gragoudas E. S., Schomacker K., Birngruber R., Hasan T. Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors. Exp Eye Res. 1996 Jan;62(1):1–10. doi: 10.1006/exer.1996.0001. [DOI] [PubMed] [Google Scholar]
  19. Schmidt-Erfurth U., Hasan T., Gragoudas E., Michaud N., Flotte T. J., Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology. 1994 Dec;101(12):1953–1961. doi: 10.1016/s0161-6420(13)31079-3. [DOI] [PubMed] [Google Scholar]
  20. Schmidt-Erfurth U., Hasan T., Schomacker K., Flotte T., Birngruber R. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med. 1995;17(2):178–188. doi: 10.1002/lsm.1900170207. [DOI] [PubMed] [Google Scholar]
  21. Star W. M., Marijnissen H. P., van den Berg-Blok A. E., Versteeg J. A., Franken K. A., Reinhold H. S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 1986 May;46(5):2532–2540. [PubMed] [Google Scholar]
  22. Wyss P., Tadir Y., Tromberg B. J., Liaw L., Krasieva T., Berns M. W. Benzoporphyrin derivative: a potent photosensitizer for photodynamic destruction of rabbit endometrium. Obstet Gynecol. 1994 Sep;84(3):409–414. [PubMed] [Google Scholar]
  23. Young L. H., Howard M. A., Hu L. K., Kim R. Y., Gragoudas E. S. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. Arch Ophthalmol. 1996 Feb;114(2):186–192. doi: 10.1001/archopht.1996.01100130180013. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES